Search results
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines...
Benzinga via Yahoo Singapore Finance· 19 hours agoThe European Medicines Agency (EMA) has accepted AstraZeneca Plc's (NASDAQ:AZN) marketing...
AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Reuters via Yahoo Singapore Finance· 1 day ago"The EMA's (European Medicines Agency) Committee for Medicinal Products for Human Use(CHMP) granted...
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Zacks via Yahoo Singapore Finance· 6 days agoData from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy...
Judge gives split ruling in Covid-19 vaccine patent legal battle
PA Media: UK News via Yahoo News Singapore· 37 minutes agoModerna’s Spikevax vaccine was the third jab to be approved for use in the UK in January 2021 after...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters via Yahoo Singapore Finance· 6 days agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Singapore Finance· 7 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Singapore Finance· 4 days agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer...
Benzinga via Yahoo Singapore Finance· 6 days agoOn Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition...
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo Singapore Finance· 4 days agoThis week, the FDA rejected Merck's MRK and AbbVie’s ABBV regulatory filings seeking approvals for...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Singapore Finance· 6 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...